News

MillerKnoll's Q1 Earnings: What Investors Should Anticipate

MillerKnoll's Q1 Earnings: What Investors Should Anticipate

MillerKnoll's Upcoming Earnings Announcement

MillerKnoll, Inc. (NASDAQ: MLKN) is preparing to release its earnings results for the first quarter of fiscal 2025 soon after the market closes. Investors are eager to see how the company has fared amidst tough market conditions.

Overview of Recent Performance

In its most recent quarter, MillerKnoll exceeded consensus earnings estimates by an impressive 26.4%, marking a notable year-over-year improvement of 63.4%. However, the company’s net sales fell short of expectations by 1.1%, showing a decline of 7.1% compared to the same quarter last year.

It’s worth noting that MillerKnoll has a strong track record of surpassing expectations, having reported earnings that exceeded consensus in each of the last four quarters, with an average surprise rate of 29.6%.

Trends in Estimates for Q1 Performance

The Zacks Consensus Estimate for MillerKnoll's first-quarter earnings per share has remained steady at 42 cents over the past few months. This figure indicates a growth of 13.5% compared to last year's EPS of 37 cents. However, the expectation for net sales is set at $892 million, reflecting an anticipated decrease of 2.8% year over year.

Factors Influencing Q1 Results

Analysts believe that the decline in MillerKnoll’s sales may be linked to persistent weaknesses in the North American housing market. This downturn is evident in the performance of its Americas Contract and Global Retail segments, pointing to a wider industry slowdown.

On a brighter note, MillerKnoll is projecting its net sales to range from $872 million to $912 million, which indicates a tighter year-over-year decrease. In the same quarter last year, net sales were around $917.7 million.

MillerKnoll seems to be managing these challenges effectively, showing improvements in both operational efficiency and profit margins. The company has benefited from new product launches and effective integration of synergies following its merger with Knoll. Strategies to optimize pricing and streamline freight, distribution, and inventory management are yielding positive results, with adjusted gross margins expected to be in the 39-40% range, an increase from the previous year's 39%.

Regarding adjusted operating expenses, MillerKnoll anticipates these will fall between $291 million and $301 million, down from the $302.7 million reported last year. The predicted adjusted EPS is expected to be between 38-44 cents, indicating an improvement over last year’s figure of 37 cents.

Earnings Predictions and Market Outlook

Despite the company’s strong past performance, our analytical model does not foresee a clear earnings beat for the next quarter. The Earnings ESP stands at 0.00%, coupled with a Zacks Rank of #3, reflecting a more cautious outlook.

Competitive Industry Insights

Within the industry landscape, other companies are also reporting mixed results. For example, Virco Manufacturing Corporation (NASDAQ: VIRC) found its earnings surpassing estimates, although sales faced hurdles. VIRC is working on business expansion strategies through potential acquisitions and initiatives to create shareholder value.

Conversely, Bassett Furniture Industries, Incorporated (NASDAQ: BSET) delivered disappointing outcomes, missing both earnings and sales expectations. Their approach involves a restructuring plan aimed at cutting costs for future growth, highlighting the need for adaptability and efficiency within the industry.

Meanwhile, Culp, Inc. (NYSE: CULP) provided mixed results, where their adjusted losses were less severe than anticipated against a backdrop of declining sales influenced by broader economic conditions. They are also considering strategic restructuring to enhance growth and profitability.

As the earnings report date approaches, many investors will be paying close attention not only to MillerKnoll's results but also to the wider trends affecting the furniture and design sector.

Frequently Asked Questions

When is MillerKnoll's Q1 earnings report scheduled?

MillerKnoll's first-quarter earnings report is expected to be released after market close.

What were the earnings expectations for MillerKnoll?

The consensus estimate for earnings per share is set at 42 cents, indicating a significant increase from last year.

How has MillerKnoll performed in previous quarters?

MillerKnoll has consistently exceeded earnings expectations over the past four quarters, averaging a surprise of 29.6%.

What external factors are affecting MillerKnoll's sales?

The ongoing challenges in the North American housing market have negatively impacted MillerKnoll's sales performance.

What trends are anticipated in MillerKnoll's financials?

Margins are expected to improve due to effective operational strategies, despite projected declines in net sales.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Nonprofit and Partners Gift Homes to Veterans

Updated Category News Views 100

A Heartfelt Gesture on Veterans Day Now this is the kind of story that gets you right in the gut. On November 9, two veterans, who were likely walking into a golf club thinking it was just another evening, were handed the keys to a future they might have only dreamt of: a mortgage-free home. Operation Finally Home, backed by the big names like Lennar and the patriotic...

Continue Reading
Surprising Week on Wall Street: Chips Drive Gains

Updated Category News Views 141

A Wild Week in Wall Street Well, folks, what a week it’s been on Wall Street. The indexes danced the cha-cha, making gains despite closing Friday on a lower note. Despite the retreat, we've got ourselves a week where the major indexes closed higher than the previous Friday. It's not the usual story, but who ever thought stocks played by the rules? The Nasdaq Composite...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 141

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 83

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
LA Fitness ELEVATE Opens at RITHM: A New Era Dawns

Updated Category News Views 66

Elevating Fitness at RITHM: A New Era Has Begun RD Management just dropped a new ace in Tampa Bay’s hand—LA Fitness ELEVATE at the RITHM at Uptown. They lit up the scene with this 30,000-square-foot beast of a gym, and I’ll tell you, it’s not your standard run-of-the-mill joint. When you toss twelve-and-a-half million bucks into a pot, you're aiming to lure folks...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 99

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 155

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Gemmy's Holiday Lights: Bright Ideas for 2026

Updated Category News Views 149

Deep in the heart of Dallas, Gemmy Industries is out to sprinkle a bit of magic over the holiday season for 2026. This ain't your grandma's string lights we're talkin' about here. We're diving headfirst into a new world of seasonal decor with tech-driven lights that look like they came straight outta a winter wonderland. And hey, if Walmart's set to host this lineup, you...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 177

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading

Top 5 Most Recently Viewed Articles

NexPoint Capital Launches Tender Offer for Shareholders

Updated Category News Views 217

NexPoint Capital Begins Tender Offer for Its Common Stock NexPoint Capital, Inc. (the "Company"), a publicly registered business development company expertly managed by NexPoint Advisors, L.P., is set to kick off a voluntary tender offer aimed at going after up to 2.5% of its outstanding common shares. This offer is designed to provide shareholders an opportunity to sell...

Continue Reading
Experience the Winter Wheat Wonderland Pop-Up by Maker's Mark

Updated Category News Views 223

Immerse Yourself in Maker's Mark's Winter Wheat Wonderland Get ready to experience something truly unique this holiday season as Maker's Mark unveils its enchanting pop-up event, the Winter Wheat Wonderland. This special event will take the vibrant spirit of Kentucky bourbon to the heart of New York City, creating a magical atmosphere for all attendees. Details of the...

Continue Reading
Innovative Muscle Composition Study Enhances Liver Transplant Care

Updated Category News Views 202

Assessment of Muscle Composition in Liver Transplant Candidates In a groundbreaking study, the utilization of AMRA Profiler 4, an advanced body-composition analysis device, was analyzed for its effectiveness in evaluating muscle composition among liver transplant candidates suffering from end-stage liver disease (ESLD). This study aims to shed light on critical health...

Continue Reading
Hansa Biopharma's Major Milestones Anticipated in 2025

Updated Category News Views 688

Hansa Biopharma's Participation in Healthcare Conferences Hansa Biopharma AB, a pioneering biopharmaceutical company, is set to make a significant presence at the 2025 J.P. Morgan Healthcare Conference. The company is renowned for its innovative approaches in addressing rare immunological disorders and has been actively engaged in developing novel therapies. This...

Continue Reading
AI for Customer Service: The Next Big Market Leap Ahead

Updated Category News Views 137

AI for Customer Service Market Growth Overview The AI for customer service market is on a remarkable trajectory, set to expand significantly over the next few years. Current projections indicate that the market size will grow from USD 12.06 billion in the near term to an impressive USD 47.82 billion by the end of the decade, achieving a compound annual growth rate (CAGR)...

Continue Reading